腫瘤患者臨床營(yíng)養(yǎng)問(wèn)題及其評(píng)估(ppt)課件_第1頁(yè)
腫瘤患者臨床營(yíng)養(yǎng)問(wèn)題及其評(píng)估(ppt)課件_第2頁(yè)
腫瘤患者臨床營(yíng)養(yǎng)問(wèn)題及其評(píng)估(ppt)課件_第3頁(yè)
腫瘤患者臨床營(yíng)養(yǎng)問(wèn)題及其評(píng)估(ppt)課件_第4頁(yè)
腫瘤患者臨床營(yíng)養(yǎng)問(wèn)題及其評(píng)估(ppt)課件_第5頁(yè)
已閱讀5頁(yè),還剩37頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、腫瘤患者臨床營(yíng)養(yǎng)問(wèn)題及其評(píng)估(ppt)(優(yōu)選)腫瘤患者臨床營(yíng)養(yǎng)問(wèn)題及其評(píng)估目錄腫瘤患者營(yíng)養(yǎng)不良現(xiàn)狀營(yíng)養(yǎng)不良對(duì)腫瘤預(yù)后的影響營(yíng)養(yǎng)不良的腫瘤患者治療現(xiàn)狀腫瘤患者營(yíng)養(yǎng)評(píng)估腫瘤患者營(yíng)養(yǎng)代謝發(fā)生改變Marn Caro MM, Laviano A, Pichard C. Nutritional intervention and quality of life in adult oncology patients. Clin Nutr. 2007 Jun;26(3):289-301.腫瘤患者隨分期升高,營(yíng)養(yǎng)攝入量明顯下降,導(dǎo)致體重丟失Ravasco P, Monteiro-Grillo I, Vidal P

2、M, et al. Cancer: disease and nutrition are key determinants of patients quality of life. Support Care Cancer. 2004 Apr;12(4):246-52.眾多內(nèi)科疾病中,腫瘤是營(yíng)養(yǎng)不良發(fā)生率最高的Meijers JM, Schols JM, van Bokhorst-de van der Schueren MA, et al. Malnutrition prevalence in The Netherlands: results of the annual dutch nationa

3、l prevalencemeasurement of care problems. Br J Nutr. 2009 Feb;101(3):417-23.近年來(lái)多個(gè)研究中的腫瘤營(yíng)養(yǎng)風(fēng)險(xiǎn)發(fā)生率Yu K, Zhou XR, He SL. A multicentre study to implement nutritional risk screening and evaluate clinical outcome and quality of life in patients with cancer. Eur J Clin Nutr. 2013Jul;67(7):732-7.不同部位腫瘤的營(yíng)養(yǎng)風(fēng)險(xiǎn)發(fā)

4、生率比較Figure 1. The prevalence ofnutritional risk at admission andat 2 weeks after admission ordischarge according to thedifferent sites of primary tumors.A at admission,B 2 weeks after admission ordischarge.PAN pancreas,CAR cardiac,STO stomach,ESO esophagus,COL colon,LIV liver,REC rectus,UN lung,BRE

5、breast.Yu K, Zhou XR, He SL. A multicentre study to implement nutritional risk screening and evaluate clinical outcome and quality of life in patients with cancer. Eur J Clin Nutr. 2013Jul;67(7):732-7.腫瘤患者發(fā)生營(yíng)養(yǎng)不良的危險(xiǎn)因素Pressoir M, Desn S, Berchery D, et al. Prevalence, risk factors and clinical implica

6、tions of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010 Mar16;102(6):966-71.化療本身會(huì)加重患者的營(yíng)養(yǎng)不良Malihi Z, Kandiah M, Chan YM, et al. Nutritional status and quality of life in patients with acute leukaemia prior to and after induction chemotherapy in three hospitals inTehran, Iran:

7、a prospective study. J Hum Nutr Diet. 2013 Jul;26 Suppl 1:123-31.目錄腫瘤患者營(yíng)養(yǎng)不良現(xiàn)狀營(yíng)養(yǎng)不良對(duì)腫瘤預(yù)后的影響營(yíng)養(yǎng)不良的腫瘤患者治療現(xiàn)狀腫瘤患者營(yíng)養(yǎng)評(píng)估腫瘤患者營(yíng)養(yǎng)狀態(tài)與全身炎癥水平密切相關(guān)Gomes de Lima KV, Maio R. Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer. Nutr Hosp. 2012 May-Jun;27(3):707-14.營(yíng)養(yǎng)不良的腫瘤患者,

8、化療相關(guān)毒副作用發(fā)生率顯著升高Barret M, Malka D, Aparicio T, et al. Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospectivemulticenter study. Oncology. 2011;81(5-6):395-402.住院期間各種并發(fā)癥發(fā)生率的比較(有營(yíng)養(yǎng)風(fēng)險(xiǎn) vs 無(wú)營(yíng)養(yǎng)風(fēng)險(xiǎn))Yu K, Zhou XR, He SL. A multice

9、ntre study to implement nutritional risk screening and evaluate clinical outcome and quality of life in patients with cancer. Eur J Clin Nutr. 2013Jul;67(7):732-7.腫瘤相關(guān)營(yíng)養(yǎng)不良降低腫瘤患者生活質(zhì)量Marn Caro MM, Laviano A, Pichard C. Nutritional intervention and quality of life in adult oncology patients. Clin Nutr.

10、 2007 Jun;26(3):289-301.體重丟失10%者,生活質(zhì)量顯著下降Nourissat A, Vasson MP, Merrouche Y, et al. Relationship between nutritional status and quality of life in patients with cancer. Eur J Cancer. 2008 Jun;44(9):1238-42.嚴(yán)重營(yíng)養(yǎng)不良患者生存率顯著低于無(wú)營(yíng)養(yǎng)不良或輕度營(yíng)養(yǎng)不良的患者Barret M, Malka D, Aparicio T, et al. Nutritional status affect

11、s treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospectivemulticenter study. Oncology. 2011;81(5-6):395-402.狀態(tài)和風(fēng)險(xiǎn)例數(shù)體重下降不良反應(yīng)RR(95% CI)a校正RR (95% CI)RR(95% CI)b校正RR (95% CI)非胃腸道相關(guān)營(yíng)養(yǎng)不良無(wú)營(yíng)養(yǎng)支持有營(yíng)養(yǎng)支持195136591.001.08(0.50-2.32)1.000.92(0.38-2.22)1.002.22(1.

12、10-4.47)1.002.95(1.36-6.36)營(yíng)養(yǎng)風(fēng)險(xiǎn)無(wú)營(yíng)養(yǎng)支持有營(yíng)養(yǎng)支持195140551.003.13(1.21-8.05)1.002.88(0.86-9.65)1.000.58(0.21-1.58)1.000.72(0.22-2.33)胃腸道相關(guān)營(yíng)養(yǎng)不良無(wú)營(yíng)養(yǎng)支持有營(yíng)養(yǎng)支持2471031441.001.28(0.58-2.83)1.001.40(0.47-4.17)1.000.64(0.26-1.55)1.006.83(1.67-27.88)營(yíng)養(yǎng)風(fēng)險(xiǎn)無(wú)營(yíng)養(yǎng)支持有營(yíng)養(yǎng)支持3591442151.001.14(0.70-1.86)1.000.9(0.50-1.62)1.000.33(0

13、.18-0.56)1.000.79(0.41-1.52)營(yíng)養(yǎng)支持治療對(duì)體重下降/不良反應(yīng)發(fā)生率的影響RR=相對(duì)危險(xiǎn)度;95% CI=95%可信限a 以年齡、性別、分期、手術(shù)和放化療進(jìn)行校正b以年齡、性別、分期和放化療進(jìn)行校正Pan H, Cai S, Ji J, et al. The impact of nutritional status, nutritional risk, and nutritional treatment on clinical outcome of 2248 hospitalized cancer patients: a multi-center,prospectiv

14、e cohort study in Chinese teaching hospitals. Nutr Cancer. 2013;65(1):62-70.營(yíng)養(yǎng)支持顯著減少化療相關(guān)毒副反應(yīng)的發(fā)生Hasenberg T, Essenbreis M, Herold A, et al. Early supplementation of parenteral nutrition is capable of improving quality of life, chemotherapy-related toxicity and bodycomposition in patients with advance

15、d colorectal carcinoma undergoing palliative treatment: results from a prospective, randomized clinical trial. Colorectal Dis. 2010Oct;12(10 Online):e190-9.腫瘤患者營(yíng)養(yǎng)治療能改善生活質(zhì)量Marn Caro MM, Laviano A, Pichard C. Nutritional intervention and quality of life in adult oncology patients. Clin Nutr. 2007 Jun;

16、26(3):289-301.接受積極營(yíng)養(yǎng)治療的腫瘤患者,生存率得到改善 The KaplanMeier survival plot ofpatients who did (n= 23) and didnot(n= 30) receive invasivenutritional support before self-expanding metal stent insertion(83.9 vs. 151.3 days,P= 0.053)Gray RT, Odonnell ME, Scott RD, et al. Impact of nutritional factors on survival

17、 in patients with inoperable oesophageal cancer undergoing self-expanding metal stentinsertion. Eur J Gastroenterol Hepatol. 2011 Jun;23(6):455-60.目錄腫瘤患者營(yíng)養(yǎng)不良現(xiàn)狀營(yíng)養(yǎng)不良對(duì)腫瘤預(yù)后的影響營(yíng)養(yǎng)不良的腫瘤患者治療現(xiàn)狀腫瘤患者營(yíng)養(yǎng)評(píng)估我國(guó)腫瘤患者營(yíng)養(yǎng)治療現(xiàn)狀 營(yíng)養(yǎng)治療的患者比例 所有住院腫瘤患者中,有34.9%接受營(yíng)養(yǎng)治療 有營(yíng)養(yǎng)風(fēng)險(xiǎn)的患者,僅46.7%得到營(yíng)養(yǎng)治療 無(wú)營(yíng)養(yǎng)風(fēng)險(xiǎn)的患者,17.1%實(shí)施了營(yíng)養(yǎng)治療 腸外營(yíng)養(yǎng)(PN) vs 腸內(nèi)營(yíng)養(yǎng)(E

18、N) 30.6%的住院腫瘤患者接受PN 4.4%的住院腫瘤患者接受EN PN:EN = 7:1Yu K, Zhou XR, He SL. A multicentre study to implement nutritional risk screening and evaluate clinical outcome and quality of life in patients with cancer. Eur J Clin Nutr. 2013Jul;67(7):732-7.臨床營(yíng)養(yǎng)的現(xiàn)狀 腸內(nèi)營(yíng)養(yǎng) 腸外營(yíng)養(yǎng)歐洲 8 : 1美國(guó) 10 : 1中國(guó) 1 : 6我國(guó)腫瘤患者營(yíng)養(yǎng)治療現(xiàn)狀惡性腫瘤營(yíng)

19、養(yǎng)不良的患病率高達(dá) 40%一 80%住院的惡性腫瘤患者中營(yíng)養(yǎng)不良的發(fā)生率就高達(dá)到63%存在營(yíng)養(yǎng)風(fēng)險(xiǎn)的患者中僅有46%得到了營(yíng)養(yǎng)治療20%的惡性腫瘤患者死于營(yíng)養(yǎng)不良目錄腫瘤患者營(yíng)養(yǎng)不良現(xiàn)狀營(yíng)養(yǎng)不良對(duì)腫瘤預(yù)后的影響營(yíng)養(yǎng)不良的腫瘤患者治療現(xiàn)狀腫瘤患者營(yíng)養(yǎng)評(píng)估 營(yíng)養(yǎng)風(fēng)險(xiǎn)篩查 21早期發(fā)現(xiàn)患者是否已發(fā)生營(yíng)養(yǎng)不良或是否存在發(fā)生營(yíng)養(yǎng)不良的危險(xiǎn)判定營(yíng)養(yǎng)不良的嚴(yán)重度及原因,指導(dǎo)制定合理的營(yíng)養(yǎng)支持的方案用以評(píng)估營(yíng)養(yǎng)支持的效果在腫瘤患者營(yíng)養(yǎng)支持的實(shí)施中,關(guān)鍵的第一步就是早期及動(dòng)態(tài)地進(jìn)行營(yíng)養(yǎng)狀態(tài)的評(píng)定。23 營(yíng)養(yǎng)篩選營(yíng)養(yǎng)的綜合評(píng)定 營(yíng)養(yǎng)評(píng)定兩步走營(yíng)養(yǎng)風(fēng)險(xiǎn)篩查工具NRS-2002PG-SGA2002 年6 月歐洲腸外腸

20、內(nèi)營(yíng)養(yǎng)學(xué)會(huì)(ESPEN) 在RCT 證據(jù)的基礎(chǔ)上制訂了適用于住院患者的營(yíng)養(yǎng)風(fēng)險(xiǎn)篩查方法NRS-2002 (nutritionalrisk screening 2002)目前唯一基于循證醫(yī)學(xué)證據(jù)(128個(gè)RCT的循證醫(yī)學(xué)基礎(chǔ)的)營(yíng)養(yǎng)風(fēng)險(xiǎn)篩查工具2006年中華醫(yī)學(xué)會(huì)腸外腸內(nèi)營(yíng)養(yǎng)學(xué)分會(huì)推薦為住院患者營(yíng)養(yǎng)風(fēng)險(xiǎn)篩查工具簡(jiǎn)便易行 (3個(gè)項(xiàng)目)、快速(5分鐘) NRS-2002營(yíng)養(yǎng)風(fēng)險(xiǎn)篩查初選表篩查項(xiàng)目是否1 BMI5% 在之前的一周中攝入量為正常的50%75%?輕度(1分) 臀部骨折 慢性疾病伴隨著急性的并發(fā) 肝硬化 COPD 長(zhǎng)期血透 糖尿病 腫瘤中度(2分) 2個(gè)月體重丟失5% BMI18.5-20.

21、5及一般狀況差 在之前的一周中攝入量為正常的25%-50%中度(2分) 大的腹部手術(shù) 中風(fēng)應(yīng)激狀況 血液系統(tǒng)的惡性腫瘤重度(3分) 1個(gè)月體重丟失5%(15%3個(gè)月) BMI18.5及一般狀況差 在之前的一周攝入量為正常的025%重度(3分) 頭部損傷 骨髓移植 ICU病人營(yíng)養(yǎng)評(píng)分 + 疾病評(píng)分 +年齡評(píng)分 = 總分年齡 : 如果70歲者,加1分 B.營(yíng)養(yǎng)篩查復(fù)篩表NRS2002內(nèi)容疾病嚴(yán)重程度評(píng)分營(yíng)養(yǎng)狀態(tài)低減評(píng)分年齡評(píng)分內(nèi)容NRS-2002營(yíng)養(yǎng)風(fēng)險(xiǎn)篩查結(jié)論總分值3:患者處于營(yíng)養(yǎng)風(fēng)險(xiǎn), 開始制訂營(yíng)養(yǎng)計(jì)劃總分值 3:每周進(jìn)行營(yíng)養(yǎng)風(fēng)險(xiǎn)篩查主觀整體營(yíng)養(yǎng)評(píng)量表(PG-SGA)PG-SGA(Patient-Generated Subjective Global Assessment,患者主觀整體評(píng)估)是在主觀整體評(píng)估(Subjective Global Ass

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論